Is a 46-year-old with serum iron 135 µg/dL, transferrin 2.42 g/L, transferrin saturation 53 % and total iron‑binding capacity 61 µmol/L normal or does this indicate iron overload such as hereditary hemochromatosis?

Abnormal Iron Studies Requiring Further Evaluation for Hereditary Hemochromatosis

This 46-year-old has abnormal iron studies with transferrin saturation of 53% that warrants further investigation for hereditary hemochromatosis, as this exceeds the diagnostic threshold of >45-55% that suggests increased risk for iron overload. 1

Interpretation of the Laboratory Values

Your patient's transferrin saturation of 53% is above the threshold that triggers concern for hereditary hemochromatosis. According to the American College of Physicians guidelines, transferrin saturation greater than 55% suggests an increased risk for hereditary hemochromatosis and the need for further investigation 1. While your patient's value of 53% is just below this 55% cutoff, it still exceeds the commonly used screening threshold of 45% that has high sensitivity for detecting C282Y homozygotes 2.

The total iron-binding capacity (TIBC) of 61 µmol/L appears low (normal range typically 45-72 µmol/L), which when combined with the elevated transferrin saturation, further supports the possibility of iron overload 3.

Critical Next Step: Measure Serum Ferritin

You must obtain a serum ferritin level immediately, as this was not included in the initial workup but is essential for case-finding. 1 The American College of Physicians explicitly recommends that both serum ferritin and transferrin saturation tests should be performed when investigating for hereditary hemochromatosis 1.

Diagnostic Thresholds to Apply:

• Serum ferritin >200 µg/L in women or >300 µg/L in men combined with transferrin saturation >55% are the criteria used for case-finding 1
• Even with transferrin saturation of 53%, an elevated ferritin would warrant genetic testing 1

Recommended Diagnostic Algorithm

Step 1: Complete the Phenotypic Assessment

• Obtain serum ferritin level (if not already done) 1
• Repeat transferrin saturation to confirm the elevation, as biological variability can affect single measurements 4

Step 2: Proceed to HFE Genetic Testing If:

• Transferrin saturation ≥45% AND/OR elevated ferritin (>200 µg/L women, >300 µg/L men) 2
• Before ordering genetic testing, discuss with the patient the risks, benefits, and limitations, including implications for disease labeling, insurability, psychological well-being, and available treatment options 1

Step 3: Interpret Genetic Results

• C282Y homozygosity: Most common cause of hereditary hemochromatosis (present in ~90% of affected patients) 1
• C282Y/H63D compound heterozygosity: Can develop iron overload in a small proportion 1
• Other genotypes or negative testing: Consider secondary causes of iron overload 5

Important Clinical Caveats

Why This Cannot Be Dismissed as "Normal"

The transferrin saturation of 53% places this patient in a gray zone where:

• It exceeds the 45% threshold commonly used for screening (high sensitivity) 2
• It approaches the 55% threshold that more specifically indicates hemochromatosis risk 1
• Biological variability means that 33% of C282Y homozygotes can have transferrin saturation below standard cut points on any single measurement 4

Potential for Serious Morbidity if Untreated

If this represents undiagnosed hereditary hemochromatosis, failure to diagnose and treat can lead to:

• Cirrhosis and hepatocellular carcinoma 1
• Diabetes mellitus (pancreatic iron deposition) 1
• Cardiomyopathy and arrhythmias 1
• Arthritis (particularly affecting metacarpophalangeal joints) 1
• Hypogonadism 1

Common Pitfall to Avoid

Do not assume normal transferrin saturation rules out iron overload if ferritin is elevated. Patients can have hyperferritinemia with normal or low transferrin saturation due to dysmetabolic iron overload syndrome or other secondary causes 5. This represents a different clinical entity requiring alternative evaluation.

If Hemochromatosis is Confirmed

Assess for Advanced Disease

• If serum ferritin >1000 µg/L or elevated liver enzymes are present, liver biopsy should be considered to assess for cirrhosis and quantify hepatic iron concentration 2
• Patients with ferritin <1000 µg/L and normal liver enzymes can proceed directly to therapeutic phlebotomy without biopsy 2

Treatment Target

• Therapeutic phlebotomy to achieve serum ferritin 50-100 µg/L 6, 2
• Maintain transferrin saturation <50-70% during maintenance therapy to prevent formation of toxic non-transferrin-bound iron 7